top of page
Search

Human Research vs Animal Research

Dr Michael Elliott MSc, D.C., CFMP.
Oct 6
3 min read

By Dr D. Michael Elliott, M.Sc., D.C., CFMP 


A headline announces that a compound protects the brain, improves metabolism or reduces kidney injury. 

It sounds encouraging. Then you read the study and discover that the experiment involved mice. 

The finding may be scientifically valuable. Its relevance to human treatment still needs to be established. 

Understanding that distinction helps us appreciate promising research while keeping our expectations realistic. 

What animal research can teach us 

Animal studies allow researchers to investigate biological processes within a living organism. 

They can explore how an intervention affects inflammation, tissue injury, metabolism or cellular signalling. They can also help identify potential risks and questions worth investigating in humans. 

This work can provide a rationale for further research. 

However, a response in an animal model does not establish that people will experience the same benefit. The US National Institute of Mental Health explicitly recognises that positive preclinical findings do not necessarily translate into positive human results. 

Why translation can be difficult 

Human illness often develops over years and involves multiple contributing factors. An experimental model may reproduce selected features of that illness over a much shorter period. 

People also vary in age, health conditions, medicines, diet and daily behaviour. 

There may be important differences in how an intervention is absorbed, distributed and metabolised. The experimental dose, route and timing may differ from what is practical or safe in clinical care. 

Researchers therefore need to establish whether the proposed mechanism produces a worthwhile benefit in people. 

A favourable animal finding is a reason to investigate—not a reliable prediction of an individual human response. 

Human research also needs careful interpretation 

“Studied in humans” is useful information, but it does not settle the question. 

A small uncontrolled study, an observational study and a well-designed randomised trial answer different questions. 

We still need to ask: 

  • Who participated, and how many people were studied? 

  • Was there an appropriate comparison group? 

  • What dose and formulation were used? 

  • How long did the study last? 

  • What benefits and adverse effects were measured? 

A human study can provide preliminary evidence without establishing routine clinical use. 

The claim should fit the strength and relevance of the research. 

A biological change is different from a clinical benefit 

Suppose an intervention changes an inflammatory marker or a measure of mitochondrial activity. 

That may help explain how it acts. Further evidence is needed to determine whether it also improves symptoms, preserves independence or reduces disease complications. 

Similarly, improved performance on a memory task in an animal model does not establish that an intervention treats human dementia. 

The outcome being measured matters as much as the species being studied. 

How to describe promising findings fairly 

Clear language preserves both the interest and the uncertainty. 

“Reduced kidney injury in an animal model” accurately describes an experimental result. 

“Protects your kidneys” makes a much broader clinical claim. 

“Being investigated for potential cognitive benefit” communicates a research direction. 

“Prevents cognitive decline” requires evidence demonstrating that outcome in the relevant human population. 

This distinction is particularly useful when discussing new supplements, peptides and other emerging interventions. 

Making the evidence visible 

In the health app I am developing, I want users to be able to distinguish established clinical applications, emerging human evidence and experimental findings. 

An experimental entry can be valuable for understanding a research direction. Its inclusion should also explain what remains unknown, including human benefit, dosing and safety. 

That allows curiosity and careful clinical judgement to work together. 

When you hear that something “works”, ask the next question: In whom, for which outcome, and under what conditions? 

 

 

 
 
bottom of page